<?xml version="1.0" encoding="utf-8"?>
<!-- Generator: Adobe Illustrator 15.0.2, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
	 width="595.28px" height="841.89px" viewBox="0 0 595.28 841.89" enable-background="new 0 0 595.28 841.89" xml:space="preserve">
<rect x="345.457" y="417.934" fill="none" stroke="#000000" stroke-width="0.7684" width="241.876" height="214.062"/>
<rect x="346.124" y="309.68" fill="none" width="238.209" height="101.346"/>
<text transform="matrix(1 0 0 1 346.124 319.6191)"><tspan x="0" y="0" fill="#ED1C24" font-family="'MyriadPro-BoldIt'" font-size="14">Comparing Antisecretory Agents</tspan><tspan x="196.11" y="0" fill="#ED1C24" font-family="'MyriadPro-Regular'" font-size="14"> </tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">PPIs are more effective and long-lasting acid inhibitors than H2RAs.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">They are superior in healing both gastric and duodenal ulcer, although </tspan><tspan x="0" y="28.801" font-family="'MyriadPro-Regular'" font-size="8">the advantage for GU is modest.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">Although H2RAs are less potent inhibitors of gastric acid secretion, </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">ulcer healing rates are comparable to PPIs with a longer duration of </tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">treatment.</tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">The clearest advantages for PPIs over H2RAs are as components of H. </tspan><tspan x="0" y="76.801" font-family="'MyriadPro-Regular'" font-size="8">pylori antibiotic regimens and for treatment of hypersecretory states </tspan><tspan x="0" y="86.4" font-family="'MyriadPro-Regular'" font-size="8">such as gastrinoma.</tspan></text>
<rect x="343.791" y="213.667" fill="none" stroke="#000000" stroke-width="0.222" width="244.209" height="200.026"/>
<rect x="6.872" y="220.358" fill="none" width="208.794" height="247.642"/>
<text transform="matrix(1 0 0 1 6.8721 230.2969)"><tspan x="0" y="0" fill="#ED1C24" font-family="'MyriadPro-BoldIt'" font-size="14">Side Effects of PPI’s:</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">Pneumonia risk</tspan><tspan x="53.759" y="9.601" font-family="'MyriadPro-Regular'" font-size="8"> because of reduction of gastric acid allows </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">colonisation of upper GI tract.</tspan><tspan x="0" y="28.801" font-family="'MyriadPro-BoldIt'" font-size="8">Community acquired pneumonia</tspan><tspan x="113.344" y="28.801" font-family="'MyriadPro-Regular'" font-size="8"> </tspan><tspan x="115.04" y="28.801" font-family="'MyriadPro-BoldIt'" font-size="8">and nosocomial pneumo</tspan><tspan x="200.052" y="28.801" font-family="'MyriadPro-BoldIt'" font-size="8">-</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-BoldIt'" font-size="8">nia on ITU.</tspan><tspan x="0" y="48" font-family="'MyriadPro-BoldIt'" font-size="8">Enteric infections- </tspan><tspan x="63.463" y="48" font-family="'MyriadPro-Regular'" font-size="8">the risk of c diff as well as salmonella/ </tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">campylobacter and other gut pathogens is increased.</tspan><tspan x="0" y="67.2" font-family="'MyriadPro-BoldIt'" font-size="8">Hypergastrinemia and carcinoid</tspan><tspan x="110.973" y="67.2" font-family="'MyriadPro-Regular'" font-size="8"> in rats on PPIs has been </tspan><tspan x="0" y="76.801" font-family="'MyriadPro-Regular'" font-size="8">observed.</tspan><tspan x="0" y="86.4" font-family="'MyriadPro-BoldIt'" font-size="8">Corpus gastritis and argyrophil cell hyperplasia,</tspan><tspan x="164.677" y="86.4" font-family="'MyriadPro-Regular'" font-size="8"> but no </tspan><tspan x="0" y="96" font-family="'MyriadPro-Regular'" font-size="8">dysplasia or cancer- this has been observed in patients treated </tspan><tspan x="0" y="105.601" font-family="'MyriadPro-Regular'" font-size="8">with omeprazole for up to 11 years.</tspan><tspan x="0" y="115.2" font-family="'MyriadPro-BoldIt'" font-size="8">Chronic atrophic gastritis-</tspan><tspan x="89.79" y="115.2" font-family="'MyriadPro-Regular'" font-size="8">occurs in 30% of patients on PPIs .</tspan><tspan x="0" y="124.801" font-family="'MyriadPro-BoldIt'" font-size="8">Vitamin B12 malabsorption-this </tspan><tspan x="111.781" y="124.801" font-family="'MyriadPro-Regular'" font-size="8">has been observed in </tspan><tspan x="0" y="134.4" font-family="'MyriadPro-Regular'" font-size="8">patients on long term PPI.</tspan><tspan x="0" y="144" font-family="'MyriadPro-BoldIt'" font-size="8">Not Iron absorption</tspan><tspan x="67.702" y="144" font-family="'MyriadPro-Regular'" font-size="8">- iron absorption does not appear to be </tspan><tspan x="0" y="153.601" font-family="'MyriadPro-Regular'" font-size="8">affected.</tspan><tspan x="0" y="163.2" font-family="'MyriadPro-BoldIt'" font-size="8">Hypochlorhydria</tspan><tspan x="58.279" y="163.2" font-family="'MyriadPro-Regular'" font-size="8">- this could reduce bone density by </tspan><tspan x="0" y="172.801" font-family="'MyriadPro-Regular'" font-size="8">inhibiting calcium absorption and is associated with a slightly </tspan><tspan x="0" y="182.4" font-family="'MyriadPro-Regular'" font-size="8">increased risk of hip fractures if &gt;50 proportional to both PPI </tspan><tspan x="0" y="192" font-family="'MyriadPro-Regular'" font-size="8">dose and duration of therapy.</tspan><tspan x="0" y="201.601" font-family="'MyriadPro-BoldIt'" font-size="8">Severe reversible hypomagnesemia</tspan><tspan x="122.228" y="201.601" font-family="'MyriadPro-Regular'" font-size="8">-has been described in </tspan><tspan x="0" y="211.2" font-family="'MyriadPro-Regular'" font-size="8">case reports.</tspan><tspan x="0" y="220.801" font-family="'MyriadPro-BoldIt'" font-size="8">In pregnancy</tspan><tspan x="44.989" y="220.801" font-family="'MyriadPro-Regular'" font-size="8"> H2 antagonists are safe and PPIs are probably </tspan><tspan x="0" y="230.4" font-family="'MyriadPro-Regular'" font-size="8">safe but less experience.</tspan></text>
<rect x="348.302" y="425.305" fill="none" width="237.031" height="188.695"/>
<text transform="matrix(1 0 0 1 348.3018 435.2441)"><tspan x="0" y="0" fill="#ED1C24" font-family="'MyriadPro-BoldIt'" font-size="14">Treatment patterns for GORD with PPI </tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">The aim is to achieve remission.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-BoldIt'" font-size="8">For Nonerosive gastroesophageal reflux disease </tspan><tspan x="166.521" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">PPIs are only useful </tspan><tspan x="0" y="28.801" font-family="'MyriadPro-Regular'" font-size="8">for hypersensitive type.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-BoldIt'" font-size="8">Prokinetic drugs </tspan><tspan x="57.814" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">increase LOS pressure, enhancing gastric emptying, </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">or improving peristalsis.</tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">Prokinetic drugs are</tspan><tspan x="66.489" y="57.601" font-family="'MyriadPro-BoldIt'" font-size="8"> </tspan><tspan x="67.961" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">not recommended as monotherapy due to side </tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">effects.</tspan><tspan x="0" y="76.801" font-family="'MyriadPro-BoldIt'" font-size="8">GABA agonists</tspan><tspan x="50.832" y="76.801" font-family="'MyriadPro-Regular'" font-size="8"> used to inhibit transient LOS relaxations- eg baclofen.</tspan><tspan x="0" y="86.4" font-family="'MyriadPro-BoldIt'" font-size="8">Intermittent therapy</tspan><tspan x="70.711" y="86.4" font-family="'MyriadPro-Regular'" font-size="8"> may be useful in mild-moderate oesophagitis.</tspan><tspan x="0" y="96" font-family="'MyriadPro-Regular'" font-size="8">With intermittent symptoms, the patient can try 2 week therapy, then </tspan><tspan x="0" y="105.601" font-family="'MyriadPro-Regular'" font-size="8">only if symptoms return can try a further 2 week course.</tspan><tspan x="0" y="115.2" font-family="'MyriadPro-Regular'" font-size="8">Intermittent PPI therapy cures 50% at 1 year.</tspan><tspan x="0" y="124.801" font-family="'MyriadPro-BoldIt'" font-size="8">Maintenance Treatment with </tspan><tspan x="101.375" y="124.801" font-family="'MyriadPro-Regular'" font-size="8">PPI’s at a higher dose are the best for </tspan><tspan x="0" y="134.4" font-family="'MyriadPro-Regular'" font-size="8">healing and preventing oesophagitis.</tspan><tspan x="0" y="144" font-family="'MyriadPro-Regular'" font-size="8">If recurrent symptoms in &lt; 3months, need continuous PPI treatment.</tspan><tspan x="0" y="153.601" font-family="'MyriadPro-Regular'" font-size="8">It is unknown if switching PPIs is clinically useful.</tspan><tspan x="0" y="163.2" font-family="'MyriadPro-BoldIt'" font-size="8">“On-demand&quot;</tspan><tspan x="47.951" y="163.2" font-family="'MyriadPro-Regular'" font-size="8"> use of PPIs might be useful for mild oesophagitis, but </tspan><tspan x="0" y="172.801" font-family="'MyriadPro-Regular'" font-size="8">usually not effective; H2 receptor antags may be better for this.</tspan></text>
<rect x="238.303" y="11.511" fill="none" width="100.666" height="43.333"/>
<text transform="matrix(1 0 0 1 238.3027 28.5508)" font-family="'MyriadPro-BoldIt'" font-size="24">PPI’s</text>
<rect x="10.33" y="39.46" fill="none" width="517.67" height="142.54"/>
<text transform="matrix(1 0 0 1 10.3301 49.3999)"><tspan x="0" y="0" fill="#ED1C24" font-family="'MyriadPro-BoldIt'" font-size="14">The phases of PPI action</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">PPI’s</tspan><tspan x="15.248" y="9.6" font-family="'MyriadPro-Regular'" font-size="6"> </tspan><tspan x="16.52" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">Irreversibly bind to and inhibit the hydrogen-potassium ATPase pump on the luminal surface of the parietal cell membrane.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">It concentrates in the acidic compartments of the parietal cell.</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">The prodrug is activated by the acid environment.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">A reactive sulfhydryl group forms a disulfide bond with a cysteine residue on the H-K-ATPase pump, thereby inactivating the enzyme.</tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">The parietal cell has to be producing acid (ie active) to be turned off.</tspan><tspan x="0" y="57.6" font-family="'MyriadPro-Regular'" font-size="8">PPIs work poorly in fasting patients or if copresscribed another antisecretory agents (H2 receptor antagonists, anticholinergic agents, or somatostatin).</tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">If the parietal is inhibited in the six hours after PPI dosing, PPI efficacy will be compromised.</tspan><tspan x="0" y="76.8" font-family="'MyriadPro-Regular'" font-size="8">PPIs are most effective when taken with or shortly before meals.</tspan><tspan x="0" y="96" font-family="'MyriadPro-Regular'" font-size="8">Because the amount of H-K-ATPase present in the parietal cell is greatest after a prolonged fast, PPIs should be administered before the first meal of the day.</tspan><tspan x="0" y="105.6" font-family="'MyriadPro-Regular'" font-size="8">PPI’s only inhibit active pumps so may need several doses to inhibit all pumps.</tspan><tspan x="0" y="115.2" font-family="'MyriadPro-Regular'" font-size="8">Once-daily PPI dosing inhibits maximal acid output by about 66 % after five days so PRN PPI is not useful.</tspan><tspan x="0" y="124.8" font-family="'MyriadPro-Regular'" font-size="8">Maximal acid secretory capacity may not be restored for 24 to 48 hours after discontinuing PPIs.</tspan></text>
<path fill="none" stroke="#000000" d="M269.135,347.646c-3.338,8.866-6.651,17.725-9.318,26.821
	c-1.803,6.145-8.129,20.115-4.734,26.349c3.259,5.983,14.684,3.196,20.347,3.878c7.392,0.892,13.897,2.775,21.456,2.185
	c1.494-4.419-4.311-12.136-6.033-16.033c-3.018-6.821-7.496-12.439-10.383-19.16c-3.631-8.452-7.612-17.608-13.334-24.706"/>
<path fill="none" stroke="#000000" d="M305.801,344.979c-1.248,9.426-7.238,16.439-6.568,26.564
	c3.371-0.553,7.834-1.39,11.135-0.997c0.822,12.007-5.895,22.78-5.133,34.999c7.742-0.252,15.49-0.605,23.229-0.961
	c7.057-0.324,11.723-0.715,8.775-8.635c-4.953-13.299-11.949-25.502-17.693-38.394c-3.195-7.175-4.869-12.218-13.643-12.476
	c-0.17,0.674-0.094,1.199-0.102,1.898"/>
<path fill="none" stroke="#000000" d="M292.467,363.646c0.08,12.017,3.748,22.243,5.355,33.675c0.857,6.096,1.805,9.047,4.311,14.27
	c1.127,2.345,2.826,5.497,1.703,8.42c-1.324,3.447-2.75,1.885-4.701,4.888c-0.346-0.051-0.871-0.555-1.15-0.49
	c-4.676,3.688-13.492,5.668-18.996,3.078c-5.026-2.363-9.562-7.853-16.478-5.396c-5.29,1.879-8.339,9.596-10.46,14.199
	c-2.518,5.463-5.512,10.891-8.916,16.023"/>
<path fill="none" stroke="#000000" d="M250.468,456.313c-0.323-5.629,7.598-19.355,11.302-23.934
	c12.594,10.217,26.346,35.428,45.754,26.586c22.777-10.375,8.256-33.67,0.533-48.144c-4.766-8.932-7.449-19.109-10.807-28.619
	c-0.719-9.031-2.5-18.937-2.115-27.889"/>
<rect x="227.135" y="416.313" fill="none" width="13.332" height="24"/>
<text transform="matrix(1 0 0 1 227.1343 420.5728)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="6">B12</tspan><tspan x="0" y="7.201" font-family="'MyriadPro-Regular'" font-size="6">Ca</tspan><tspan x="0" y="14.4" font-family="'MyriadPro-Regular'" font-size="6">Mg</tspan></text>
<g>
	<g>
		<line fill="none" stroke="#000000" x1="249.135" y1="436.313" x2="241.135" y2="428.979"/>
		<path d="M236.686,424.9c2.805,1.143,6.617,2.197,9.514,2.271l-4.48,2.342l-1.945,4.668
			C239.449,431.303,238.067,427.596,236.686,424.9z"/>
	</g>
</g>
<rect x="282.469" y="432.313" fill="none" width="34.666" height="14"/>
<text transform="matrix(1 0 0 1 282.4683 436.5723)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="6">Hypergastrin</tspan><tspan x="0" y="7.199" font-family="'MyriadPro-Regular'" font-size="6">Atrophy</tspan></text>
<g>
	<path fill="none" stroke="#000000" stroke-width="0.8481" d="M250.768,521.102c-5.07-3.363-11.393-11.701-10.143-19.549
		c1.947,0.629,2.949,0.006,4.234,0.988c-3.189-4.717-4.18-16.236,2.525-17.605c0.252,1.672,1.076,3.633,1.15,5.348
		c-1.912-7.846,7.072-20.084,12.863-9.125c1.482-5.781,4.776-7.525,9.373-6.682c5.049,0.928,5.361,7.615,8.501,8.559
		c6.71,2.02,15.466-9.803,17.097,5.494c0.625-5.164,6.883-11.152,9.391-14.047c1.182,5.361,3.451,10.34,5.508,15.275
		c1.412-8.613,6.541-25.109,14.982-26.389c0.838,4.756,1.932,10.033,1.494,15.174c8.719-2.076,8.391,5.85,7.682,14.119
		c-2.902,0.311-2.59,1.885-4.559,3.037c3.041,4.27,5.508,10.482,4.555,16.719c-1.59-0.248-3.543,0.664-5.217,0.113
		c5.434,3.258,4.652,10.746,3.811,16.826c-0.988,0.354-1.99,0.428-3.008,0.215"/>
	<path fill="none" stroke="#000000" stroke-width="0.8481" d="M322.984,535.217c-4.197-1.148-6.439-9.824-2.656-12.736
		c-4.254-0.082-5.154-4.785-4.025-9.596c0.512,0.373,1.814-0.844,2.209-1.107c0.031,0.732-0.094,1.432-0.371,2.094
		c-1.295-3.773-1.201-10.291,0-14.932c0.379,8.051-8.516,5.295-13.324,5.021c0-1.07-0.094-2.463-0.143-3.576
		c-1.275,16.807-9.516,1.725-14.363-0.355c-5.238-2.246-16.648,4.928-15.471-9.582c0.57,20.576-6.01,10.846-15.844,4.33
		c-0.751,4.242,0.771,7.145,4.182,8.221c0.547,2.318,0.563,7.084,0.026,9.42c-1.173-0.221-2.737,0.363-4.044,0.113
		c3.941,3.92,5.004,21.215,1.924,22.686"/>
</g>
<rect x="4" y="216.358" fill="none" stroke="#000000" stroke-width="0.222" width="219.666" height="332.142"/>
<rect x="6.33" y="35.5" fill="none" stroke="#000000" stroke-width="0.222" width="530.669" height="173.161"/>
<rect x="349.224" y="639" fill="none" width="223.11" height="183.667"/>
<text transform="matrix(1 0 0 1 349.2236 647.5195)"><tspan x="0" y="0" fill="#ED1C24" font-family="'MyriadPro-BoldIt'" font-size="12">Refractory GORD Causes:</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">Nocturnal acid breakthrough</tspan><tspan x="100.302" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">-Up to 70 % of patients taking PPIs </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">bd gastric pH &lt;4 lasting for &gt;60 minutes, particularly at night.</tspan><tspan x="0" y="28.801" font-family="'MyriadPro-BoldIt'" font-size="8">Incorrect timing with food</tspan><tspan x="89.222" y="28.801" font-family="'MyriadPro-Regular'" font-size="8"> as administration 15-30 minutes </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">pre-meals is preferable.</tspan><tspan x="0" y="48" font-family="'MyriadPro-BoldIt'" font-size="8">Effect of dosing interval</tspan><tspan x="81.373" y="48" font-family="'MyriadPro-Regular'" font-size="8"> — BD dosing may improve gastric acid </tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">suppression in some.</tspan><tspan x="0" y="67.2" font-family="'MyriadPro-BoldIt'" font-size="8">Differences in metabolism</tspan><tspan x="89.526" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">-because of variability in cytochrome </tspan><tspan x="0" y="76.801" font-family="'MyriadPro-Regular'" font-size="8">systems.</tspan><tspan x="0" y="86.4" font-family="'MyriadPro-BoldIt'" font-size="8">Gastric acid hypersecretion</tspan><tspan x="93.55" y="86.4" font-family="'MyriadPro-Regular'" font-size="8"> eg  Zollinger-Ellison or idiopathic.</tspan><tspan x="0" y="96" font-family="'MyriadPro-BoldIt'" font-size="8">Helicobacter pylori - </tspan><tspan x="70.808" y="96" font-family="'MyriadPro-Regular'" font-size="8">although its precise role in this context is </tspan><tspan x="0" y="105.601" font-family="'MyriadPro-Regular'" font-size="8">unknown.</tspan><tspan x="0" y="115.2" font-family="'MyriadPro-BoldIt'" font-size="8">Omeprazole resistance</tspan><tspan x="78.808" y="115.2" font-family="'MyriadPro-Regular'" font-size="8"> is a rare condition that is presumably </tspan><tspan x="0" y="124.801" font-family="'MyriadPro-Regular'" font-size="8">caused by mutations of the proton pump. Affected patients can be </tspan><tspan x="0" y="134.4" font-family="'MyriadPro-Regular'" font-size="8">treated with H2 antagonists.</tspan><tspan x="0" y="144" font-family="'MyriadPro-BoldIt'" font-size="8">Delayed healing</tspan><tspan x="56.095" y="144" font-family="'MyriadPro-Regular'" font-size="8">- those with severe esophagitis may take longer </tspan><tspan x="0" y="153.601" font-family="'MyriadPro-Regular'" font-size="8">to heal than 8 weeks.</tspan></text>
<rect x="6.872" y="578.395" fill="none" width="275.458" height="168.939"/>
<text transform="matrix(1 0 0 1 6.8721 588.334)"><tspan x="0" y="0" fill="#ED1C24" font-family="'MyriadPro-BoldIt'" font-size="14">Approaches to refractory GORD</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">Consideration of Other Causes</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">In patients in whom the adequacy of acid suppression is in question, do a 24-hour </tspan><tspan x="0" y="28.801" font-family="'MyriadPro-Regular'" font-size="8">pH study while taking medications.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">The likelihod of 24 hour ph study on PPI abnormal is low, so should consider other </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">causes too.</tspan><tspan x="0" y="57.601" font-family="'MyriadPro-BoldIt'" font-size="8">Consideration of manometry.</tspan><tspan x="0" y="67.2" font-family="'MyriadPro-BoldIt'" font-size="8">Esophageal multichannel intraluminal impedance.</tspan><tspan x="0" y="76.801" font-family="'MyriadPro-BoldIt'" font-size="8">Increasing the frequency of dosing</tspan><tspan x="118.173" y="76.801" font-family="'MyriadPro-Regular'" font-size="8"> and offer bd treatment esp before dinner.</tspan><tspan x="0" y="96" font-family="'MyriadPro-BoldIt'" font-size="8">Increasing the dose-</tspan><tspan x="69.095" y="96" font-family="'MyriadPro-Regular'" font-size="8">can have a beneficial effect.</tspan><tspan x="0" y="105.601" font-family="'MyriadPro-BoldIt'" font-size="8">The addition of a second, prokinetic drug</tspan><tspan x="140.406" y="105.601" font-family="'MyriadPro-Regular'" font-size="8"> eg domperidone-may be helpful but </tspan><tspan x="0" y="115.2" font-family="'MyriadPro-Regular'" font-size="8">little evidence base.</tspan><tspan x="0" y="134.4" font-family="'MyriadPro-BoldIt'" font-size="8">Switching to another drug</tspan><tspan x="89.638" y="134.4" font-family="'MyriadPro-Regular'" font-size="8"> —might help but no real evidence.</tspan><tspan x="0" y="144" font-family="'MyriadPro-BoldIt'" font-size="8">Antireflux surgery</tspan><tspan x="61.943" y="144" font-family="'MyriadPro-Regular'" font-size="8">- This should be considered in patients who require high doses </tspan><tspan x="0" y="153.601" font-family="'MyriadPro-Regular'" font-size="8">of PPI to control symptoms, esp young patients who may require lifelong therapy.</tspan></text>
<g>
	<g>
		<line fill="none" stroke="#000000" x1="245.041" y1="812.11" x2="303.041" y2="812.11"/>
		<path d="M309.076,812.11c-2.84,1.054-6.363,2.852-8.547,4.755l1.72-4.755l-1.72-4.755
			C302.713,809.259,306.236,811.058,309.076,812.11z"/>
	</g>
</g>
<rect fill="none" stroke="#010101" stroke-width="3" width="595.28" height="843.998"/>
<rect x="7.333" y="669.333" fill="none" width="249" height="10"/>
<text transform="matrix(1 0 0 1 7.333 675.0127)" font-family="'MyriadPro-Regular'" font-size="8">NB bd lansoprazole is equivalent to switching to od 40mg esomeprazole.</text>
<rect x="7" y="706.667" fill="none" width="304" height="8.333"/>
<text transform="matrix(1 0 0 1 7 712.3467)" font-family="'MyriadPro-Regular'" font-size="8">H2 antagonists are not as effective as PPIs and patients can develop tolerance after 1 week.</text>
<rect x="6.872" y="753.334" fill="none" width="306.001" height="75.333"/>
<text transform="matrix(1 0 0 1 6.8721 763.2734)"><tspan x="0" y="0" fill="#ED1C24" font-family="'MyriadPro-BoldIt'" font-size="14">Risk factors for poor response to medical therapy:</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">Nocturnal reflux on 24 hour pH study.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">Structurally deficient  LOS.</tspan><tspan x="0" y="28.801" font-family="'MyriadPro-Regular'" font-size="8">Mixed duodenal and gastric reflux. </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">Mucosal injury at presentation.</tspan></text>
<rect x="346.124" y="218.667" fill="none" width="230.667" height="61"/>
<text transform="matrix(1 0 0 1 346.124 228.6069)"><tspan x="0" y="0" fill="#ED1C24" font-family="'MyriadPro-BoldIt'" font-size="14">PPI Comparison with Other PPI’s</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">The most bioavailable are lansoprazole/dexlansoprazole and </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">pantoprazole.</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">Rabeprazole has the fastest onset of action.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">Pantoprazole is the most ‘gastro-specific’; it binds to cysteine </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">residues 813 and 822 within the alpha-subunit of the proton pump.</tspan></text>
<a xlink:href="http://www.gastroenterologybook.com/" >
	<rect x="430.449" y="822.001" fill="none" width="144.773" height="11.333"/>
	<text transform="matrix(1 0 0 1 430.4492 830.5205)" fill="#00A651" font-family="'MyriadPro-Regular'" font-size="12">Written by Dr Sebastian Zeki</text>
</a>
</svg>
